KRW 33050.0
(-1.34%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -24.27 Billion KRW | 0.61% |
2022 | -24.42 Billion KRW | 6.98% |
2021 | -26.26 Billion KRW | -502.83% |
2020 | -4.35 Billion KRW | 80.58% |
2019 | -22.43 Billion KRW | -746.41% |
2018 | 3.47 Billion KRW | 159.26% |
2017 | -5.85 Billion KRW | -60.65% |
2016 | -3.64 Billion KRW | -1022.87% |
2015 | 395.02 Million KRW | 119.53% |
2014 | -2.02 Billion KRW | 49.07% |
2013 | -3.97 Billion KRW | 72.57% |
2012 | -14.47 Billion KRW | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -5.44 Billion KRW | 48.69% |
2024 Q2 | -5.71 Billion KRW | -4.88% |
2023 Q1 | -5.28 Billion KRW | -15.97% |
2023 Q3 | -4.51 Billion KRW | -17.21% |
2023 Q4 | -10.62 Billion KRW | -134.99% |
2023 FY | -24.27 Billion KRW | 0.61% |
2023 Q2 | -3.85 Billion KRW | 27.02% |
2022 Q4 | -4.55 Billion KRW | 29.58% |
2022 Q3 | -6.47 Billion KRW | -12.78% |
2022 Q1 | -7.66 Billion KRW | -43.59% |
2022 FY | -24.42 Billion KRW | 6.98% |
2022 Q2 | -5.73 Billion KRW | 25.17% |
2021 Q2 | -5.04 Billion KRW | 47.21% |
2021 Q4 | -5.33 Billion KRW | 15.52% |
2021 Q1 | -9.55 Billion KRW | -399.64% |
2021 FY | -26.26 Billion KRW | -502.83% |
2021 Q3 | -6.31 Billion KRW | -25.25% |
2020 Q2 | 5.78 Billion KRW | 189.78% |
2020 Q1 | -6.44 Billion KRW | 18.93% |
2020 Q4 | 3.18 Billion KRW | 146.31% |
2020 FY | -4.35 Billion KRW | 80.58% |
2020 Q3 | -6.88 Billion KRW | -218.96% |
2019 Q2 | -6.44 Billion KRW | -44.41% |
2019 FY | -22.43 Billion KRW | -746.41% |
2019 Q4 | -7.95 Billion KRW | -113.08% |
2019 Q3 | -3.73 Billion KRW | 42.11% |
2019 Q1 | -4.46 Billion KRW | -145.86% |
2018 Q1 | -836.17 Million KRW | 59.17% |
2018 Q3 | -4.21 Billion KRW | -220.93% |
2018 FY | 3.47 Billion KRW | 159.26% |
2018 Q4 | 9.73 Billion KRW | 330.93% |
2018 Q2 | -1.31 Billion KRW | -57.13% |
2017 FY | -5.85 Billion KRW | -60.65% |
2017 Q3 | -1.33 Billion KRW | -17.63% |
2017 Q4 | -2.04 Billion KRW | -52.97% |
2017 Q2 | -1.13 Billion KRW | 14.52% |
2017 Q1 | -1.33 Billion KRW | 63.58% |
2016 Q3 | -886.57 Million KRW | 75.44% |
2016 Q1 | -697.53 Million KRW | -1035.97% |
2016 Q2 | -3.61 Billion KRW | -417.58% |
2016 FY | -3.64 Billion KRW | -1022.87% |
2016 Q4 | -3.65 Billion KRW | -312.43% |
2015 Q3 | 1.38 Billion KRW | 478.49% |
2015 Q4 | -61.4 Million KRW | -104.44% |
2015 Q2 | -365.67 Million KRW | 34.92% |
2015 Q1 | -561.92 Million KRW | 63.01% |
2015 FY | 395.02 Million KRW | 119.53% |
2014 Q1 | -52.45 Million KRW | 98.73% |
2014 FY | -2.02 Billion KRW | 49.07% |
2014 Q4 | -1.51 Billion KRW | -804.23% |
2014 Q3 | -168 Million KRW | 40.59% |
2014 Q2 | -282.77 Million KRW | -439.05% |
2013 Q2 | -3.98 Million KRW | -100.47% |
2013 Q3 | -698.44 Million KRW | -17443.48% |
2013 Q1 | 853.84 Million KRW | 105.62% |
2013 Q4 | -4.12 Billion KRW | -490.21% |
2013 FY | -3.97 Billion KRW | 72.57% |
2012 Q4 | -15.18 Billion KRW | -9617.51% |
2012 FY | -14.47 Billion KRW | 0.0% |
2012 Q3 | 159.52 Million KRW | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
BCWORLD PHARM. Co., Ltd. | 2.63 Billion KRW | 1021.847% |